EUVIMEDEUVIMED entdecken
Crossref

The Prebiotic 2′-Fucosyllactose Ameliorates Colitis via an Akkermansia muciniphila -Mediated Prebiotic-Microbiota-Metabolite Axis

Ruizhi Xia, Jiaying Ge, Yuying Shuai iD

Journal of Agricultural and Food Chemistry · 17.06.2026 · 74 (23) · 17898-17912

DOI: 10.1021/acs.jafc.5c15443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 05.06.2026. Verfasst von Ruizhi Xia und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China. Hauptthemen laut MEDLINE: Trisaccharides, Colitis, Prebiotics, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, Zhejiang Chinese Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies indicate that 2′-fucosyllactose (2′-FL), a human milk oligosaccharide, alleviates inflammatory bowel disease (IBD) by modulating the gut microbiota, yet the underlying mechanisms and key functional bacteria involved remain unclear. This study employed fecal microbiota transplantation and an antibiotic-treated mouse model to investigate the role of 2′-FL-mediated gut microbiota in lipopolysaccharide-induced colitis, with a focus on Akkermansia muciniphila (A. muciniphila). Results demonstrated that 2′-FL intervention significantly enriched A. muciniphila in the gut and promoted the production of short-chain fatty acids (SCFAs). Fecal microbiota transplantation experiments confirmed that 2′-FL-modulated microbiota reshaped the gut ecosystem in recipient mice. Notably, monocolonization with A. muciniphila alone alleviated colitis, while coadministration of 2′-FL synergistically enhanced anti-inflammatory effects and SCFAs production. These findings reveal that 2′-FL operates via a “prebiotic-key bacterium-metabolite” axis, wherein A. muciniphila acts as a mediator to metabolize 2′-FL into SCFAs, orchestrating anti-inflammatory and barrier-protective responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrisaccharidesColitisPrebioticsGastrointestinal MicrobiomeAkkermansiaAnimalsMiceHumansMaleMice, Inbred C57BLFatty Acids, Volatile

Stichwörter der Autor:innen

2′-fucosyllactoseAkkermansia muciniphilafecal microbiota transplantationgut microbiotainflammatory bowel diseaseshort-chain fatty acids

Substanzen

TrisaccharidesPrebiotics2'-fucosyllactoseFatty Acids, Volatile

Autor:innen und Institutionen

  • College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.

ORCID-Profile: Yuying Shuai

Förderung

  • Natural Science Foundation of Zhejiang Province
  • Zhejiang Chinese Medical University

Zitieren

APA

Xia, R., Ge, J., & Shuai, Y. (2026). The Prebiotic 2′-Fucosyllactose Ameliorates Colitis via an Akkermansia muciniphila -Mediated Prebiotic-Microbiota-Metabolite Axis. Journal of Agricultural and Food Chemistry, 74(23), 17898-17912. https://doi.org/10.1021/acs.jafc.5c15443

Vancouver

Xia R, Ge J, Shuai Y. The Prebiotic 2′-Fucosyllactose Ameliorates Colitis via an Akkermansia muciniphila -Mediated Prebiotic-Microbiota-Metabolite Axis. Journal of Agricultural and Food Chemistry. 2026;74(23):17898-17912. doi:10.1021/acs.jafc.5c15443

BibTeX
@article{Xia2026,
  author = {Xia, Ruizhi and Ge, Jiaying and Shuai, Yuying},
  title = {The Prebiotic 2′-Fucosyllactose Ameliorates Colitis via an Akkermansia muciniphila -Mediated Prebiotic-Microbiota-Metabolite Axis},
  journal = {Journal of Agricultural and Food Chemistry},
  year = {2026},
  volume = {74},
  number = {23},
  pages = {17898--17912},
  doi = {10.1021/acs.jafc.5c15443}
}
Kostenlos starten →